118 related articles for article (PubMed ID: 24300873)
1. No increase in Epstein-Barr virus viral load in a group of 30 asymptomatic patients with Crohn's disease.
Fernandez Salazar L; Rojo S; De Lejarazu RO; Castro E; Higuera E; González JM
Am J Gastroenterol; 2013 Dec; 108(12):1933-5. PubMed ID: 24300873
[No Abstract] [Full Text] [Related]
2. Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab.
Francolla KA; Altman A; Sylvester FA
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):193-5. PubMed ID: 18664872
[No Abstract] [Full Text] [Related]
3. Epstein-Barr virus-associated lymphoma in Crohn's disease.
Losco A; Gianelli U; Cassani B; Baldini L; Conte D; Basilisco G
Inflamm Bowel Dis; 2004 Jul; 10(4):425-9. PubMed ID: 15475752
[TBL] [Abstract][Full Text] [Related]
4. [Bone marrow toxicity secondary to a primary Epstein-Barr infection in a patient with Crohn's disease on thiopurines treatment].
Ruiz Hernández C; Sánchez Hernández D; Vila Miravet V; Pinillos Pisón S; Martin de Carpi J
An Pediatr (Barc); 2015 Aug; 83(2):134-5. PubMed ID: 25841315
[No Abstract] [Full Text] [Related]
5. Epstein-Barr virus-positive mucocutaneous ulcer in Crohn's disease. A condition to consider in immunosuppressed IBD patients.
Juan A; Lobatón T; Tapia G; Mañosa M; Cabré E; Domènech E
Dig Liver Dis; 2017 Aug; 49(8):934-937. PubMed ID: 28454852
[TBL] [Abstract][Full Text] [Related]
6. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.
Peyrin-Biroulet L; Oussalah A; Williet N; Pillot C; Bresler L; Bigard MA
Gut; 2011 Jul; 60(7):930-6. PubMed ID: 21228429
[TBL] [Abstract][Full Text] [Related]
7. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
Orii T; Ohkohchi N; Satomi S; Hoshino Y; Kimura H
Transpl Int; 2002 Nov; 15(11):529-34. PubMed ID: 12461655
[TBL] [Abstract][Full Text] [Related]
8. Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease.
N'guyen Y; Andreoletti L; Patey M; Lecoq-Lafon C; Cornillet P; Léon A; Jaussaud R; Fieschi C; Strady C
J Clin Microbiol; 2009 Apr; 47(4):1252-4. PubMed ID: 19193838
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy.
Reijasse D; Le Pendeven C; Cosnes J; Dehee A; Gendre JP; Nicolas JC; Beaugerie L
Inflamm Bowel Dis; 2004 Mar; 10(2):85-90. PubMed ID: 15168806
[TBL] [Abstract][Full Text] [Related]
10. EBV hepatitis in a young Crohn's disease patient on prolonged remission with azathioprine.
Angelucci E; Cesarini M; Caturelli E; Vernia P
Inflamm Bowel Dis; 2011 Feb; 17(2):E1. PubMed ID: 20848464
[No Abstract] [Full Text] [Related]
11. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
Sagüés M; Navarro JT; Ribera JM; Millá F
Med Clin (Barc); 2012 Apr; 138(8):366-7. PubMed ID: 21752407
[No Abstract] [Full Text] [Related]
12. Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.
Serrate C; Silva-Moreno M; Dartigues P; Poujol-Robert A; Sokol H; Gorin NC; Coppo P
Inflamm Bowel Dis; 2009 Oct; 15(10):1449-51. PubMed ID: 19177429
[No Abstract] [Full Text] [Related]
13. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
Ben Hriz F; Habbessi H; Maamouri N; Belkahla N; Ouerdiane S; Chouaib S; Ouerghi H; Chaabouni H; Ben Mami N
Tunis Med; 2009 Aug; 87(8):545-6. PubMed ID: 20180364
[No Abstract] [Full Text] [Related]
14. Epstein-Barr virus and human herpesvirus type 6 infection in patients with psoriasis.
Neimann AL; Hodinka RL; Joshi YB; Elkan M; Van Voorhees AS; Gelfand JM
Eur J Dermatol; 2006; 16(5):548-52. PubMed ID: 17101477
[TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease].
Juffermans NP; Jager A; Kersten MJ; van Oers MH; Hommes DW
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1859-63. PubMed ID: 16128185
[TBL] [Abstract][Full Text] [Related]
16. [From research to clinic: The case of Crohn's disease and Tumor Necrosis Factor].
Pellicano R
Minerva Gastroenterol Dietol; 2000 Jun; 46(2):131-8. PubMed ID: 19320082
[No Abstract] [Full Text] [Related]
17. Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia.
Martelius T; Lappalainen M; Aalto SM; Nihtinen A; Hedman K; Anttila VJ
Clin Microbiol Infect; 2010 Jun; 16(6):657-62. PubMed ID: 19694766
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and parvovirus B19 coinfection in a Crohn's disease patient under azathioprine.
Moreira T; Lago P; Salgado M; Pimentel R
Inflamm Bowel Dis; 2010 Jun; 16(6):905-6. PubMed ID: 19760779
[No Abstract] [Full Text] [Related]
20. Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study.
Linton MS; Kroeker K; Fedorak D; Dieleman L; Fedorak RN
Aliment Pharmacol Ther; 2013 Nov; 38(10):1248-54. PubMed ID: 24053733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
